Digital biomarkers: The future of healthcare

Globally and annually, trillions of dollars and data are wasted in the traditional healthcare industry.1

The total time we spend in a traditional medical setting getting checked for a potential disease accounts for only a tiny fraction of the total time we spend living in our life settings.  And, according to a recent survey in the US, over half of primary care physicians spend less than 16 minutes with a patient per consultation.2 This leads to data that is far too often siloed, unstructured, and intermittently generated, hindering its ability to be used efficiently within our healthcare system.  

The vast majority of the time we spend living our lives is outside the traditional medical setting – in the life setting – a place that provides access to a significantly larger window to observe the signs of disease.  However, thus far, there have been a lack of solutions to measure these signs. 

Moreover, the traditional medical setting continues to rely on costly and invasive approaches that are also inaccessible to everyday consumers without a physician’s involvement.  This often creates a barrier to accessibility, affordability, and convenience, by requiring a physical intermediary (such as blood or tissue) to be measured to map or “mark” a disease (known as biomarkers).